23andMe Awarded Their First Patent

Following on from my post about my attendance at the Architecture for Life conference at the Kennedy School of Government I would like to direct readers to a very interesting and informative article. The article entitled ‘Patenting and Personal Genomics: 23andMe Receives its First Patent, and Plenty of Questions’ appears on the Genomics Law Report ... 23andMe Awarded Their First Patent

Jonathan Hankins

More Medical Patent Problems

Last month the US Supreme Court unanimously ruled that that the personalized medicine dosing process invented by Prometheus is not eligible for patent protection because the process is effectively an unpatentable law of nature. This decision reverses the Court of Appeals for the Federal Circuit’s holding that the claims were patentable because they included substantial ... More Medical Patent Problems

Redazione FGB

Intellectual Property and Responsibility (part 3)

Professor Biagioli was kind enough to dedicate some of his time to the Foundation in the form of a conversation with Jonathan Hankins. Topics covered were varied, but the major theme running through the discussion is responsibility in the patenting process. Many extremely interesting points came up, from how to lessen constraints on scientific research ... Intellectual Property and Responsibility (part 3)

Jonathan Hankins

Intellectual Property and Responsibility (part 2)

Professor Biagioli was kind enough to dedicate some of his time to the Foundation in the form of a conversation with Jonathan Hankins. Topics covered were varied, but the major theme running through the discussion is responsibility in the patenting process. Many extremely interesting points came up, from how to lessen constraints on scientific research ... Intellectual Property and Responsibility (part 2)

Jonathan Hankins

Intellectual Property and Responsibility

Professor Mario Biagioli is a Distinguished Professor of Law and Science and Technology Studies (STS), and Director of the new Center for Innovation Studies at University of California, Davis. To quote the website the Innovation studies center’s research “engages the many dimensions of the process of technoscientific innovation, from those that make it possible to ... Intellectual Property and Responsibility

Jonathan Hankins

The Genes and Patent issue

On Friday 30th October The New York Times business section carried an article entitled ‘US Says Genes Should Not Be Eligible For Patents’ written by Andrew Pollack. In the article the author explains that ‘Reversing a longstanding policy, the federal government said on Friday that human and other genes should not be eligible for patents ... The Genes and Patent issue

Redazione FGB

Marcia indietro sulla brevettabilità dei geni

Nelle scorse settimane, in occasione del decennale del sequenziamento del genoma umano, molti media soprattutto all’estero hanno riservato ampi spazi alle prospettive offerte dalle nuove tecnologie del Dna. Uno speciale di sette articoli, sul settimanale inglese The Economist ha esaminato la questione anche dal punto di vista delle ricadute economiche e sociali, oltre che mediche ... Marcia indietro sulla brevettabilità dei geni

Margherita Fronte